Aridis Pharmaceuticals, Inc. (ARDS)
NCM · Common · CUSIP 040334104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ARDS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
040334104
Market Cap
Small Cap · $269 Million
IPO
8/13/2018 · $13.00/share
Business: Aridis Pharmaceuticals,Inc. biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases. Complementing the product pipeline is a disruptive platform technology to discover rare, potent human monoclonal antibodies from patients.

Company Contact

CEO
Vu Truong, Ph.D.
CFO
Fred Kurland
Headquarters
983 University Avenue, Bldg. B, Los Gatos, CA 95032
Phone
408-385-1742
Fax
408-960-3822
Investor Relations
Jonathon Brzezinski, Tiberend Strategic Advisors · 212-375-2681 · jbrzezinski@tiberend.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »